Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
- PMID: 36224173
- PMCID: PMC9556711
- DOI: 10.1038/s41467-022-33415-5
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
Erratum in
-
Author Correction: Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study.Nat Commun. 2022 Nov 1;13(1):6540. doi: 10.1038/s41467-022-34344-z. Nat Commun. 2022. PMID: 36319644 Free PMC article. No abstract available.
Abstract
With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.PLoS Med. 2025 Jan 23;22(1):e1004511. doi: 10.1371/journal.pmed.1004511. eCollection 2025 Jan. PLoS Med. 2025. PMID: 39847575 Free PMC article.
-
Long COVID and recovery from Long COVID: quality of life impairments and subjective cognitive decline at a median of 2 years after initial infection.BMC Infect Dis. 2024 Nov 5;24(1):1241. doi: 10.1186/s12879-024-10158-w. BMC Infect Dis. 2024. PMID: 39497076 Free PMC article.
-
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28. J Infect. 2023. PMID: 37777159
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
-
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2. Cochrane Database Syst Rev. 2021. PMID: 33624299 Free PMC article.
Cited by
-
The global health and economic value of COVID-19 vaccination.BMJ Glob Health. 2024 Sep 7;9(9):e015031. doi: 10.1136/bmjgh-2024-015031. BMJ Glob Health. 2024. PMID: 39244220 Free PMC article.
-
Post-COVID dysautonomias: what we know and (mainly) what we don't know.Nat Rev Neurol. 2024 Feb;20(2):99-113. doi: 10.1038/s41582-023-00917-9. Epub 2024 Jan 11. Nat Rev Neurol. 2024. PMID: 38212633 Review.
-
Specific persistent symptoms of COVID-19 and associations with reinfection: a community-based survey study in southern China.Front Public Health. 2024 Sep 3;12:1452233. doi: 10.3389/fpubh.2024.1452233. eCollection 2024. Front Public Health. 2024. PMID: 39290408 Free PMC article.
-
Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care.Int J Environ Res Public Health. 2022 Dec 15;19(24):16841. doi: 10.3390/ijerph192416841. Int J Environ Res Public Health. 2022. PMID: 36554723 Free PMC article.
-
Neurobiology of long-COVID: Hypotheses and unanswered questions.Anaesth Crit Care Pain Med. 2023 Jun;42(3):101201. doi: 10.1016/j.accpm.2023.101201. Epub 2023 Feb 15. Anaesth Crit Care Pain Med. 2023. PMID: 36801258 Free PMC article. No abstract available.
References
-
- WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond... (2021). - PMC - PubMed
-
- Domingo, F.R. et al. Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review. Preprint at medRxiv10.1101/2021.06.03.21258317 (2021).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous